Predicting Maternal and Fetal Exposures of Elexacaftor-Tezacaftor-Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

By sjmartinez • May 6, 2025

Hong E, Hebert MF, Fay E, Turner G, Eshaghian P, Trimble A, Chung PS, Rao AP, Beringer PM. Predicting Maternal and Fetal Exposures of Elexacaftor-Tezacaftor-Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models. Clin Pharmacol Ther. 2025 May 5. doi: 10.1002/cpt.3705. Epub ahead of print. PMID: 40323155.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

KIDNEY AGING and CHRONIC KIDNEY DISEASE – Another Perspective

Glassock RJ, Rule AD, Denic A, Delanaye P. KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective. Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093/ndt/gfaf087.[...]

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society

Arlien-Søborg MC, Radovick S, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev[...]

Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides

Qin M, Evron E, Tran PT, Deng M, Nelson AM, Kim J, Agak GW. Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides.[...]